share_log

Aerie Pharmaceuticals Q3 EPS $(0.27) Up From $(0.72) YoY, Sales $36.13M Up From $29.31M YoY

Benzinga Real-time News ·  Nov 3, 2022 17:08

Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.27) per share. This is a 62.5 percent increase over losses of $(0.72) per share from the same period last year. The company reported $36.13 million in sales this quarter. This is a 23.25 percent increase over sales of $29.31 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment